Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03789162 · ClinicalTrials.gov registry record
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
A clinical trial of Colorectal Cancer, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 850
- Enrollment target
- 20
- Study locations
NCT03789162: Completed study of Colorectal Cancer, sponsored by Exact Sciences Corporation.
NCT03789162 is a study of Colorectal Cancer that has completed, run by Exact Sciences Corporation. The registered enrollment target is 850 participants, below the 1,542-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (45% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03789162, a study of Colorectal Cancer, has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 850 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for the detection of colorectal cancer (CRC).
Primary Outcome
The outcomes are co-primary. Biomarkers under evaluation include differential methylation of nucleic acids and altered expression of proteins in stool from subjects with confirmed colorectal cancer at the pre-intervention stage.
Conditions Studied
Study Locations (20)
California
- Alliance Research Institute - Canoga Park
- GW Research Inc - Chula Vista
- Tilda Research - Laguna Hills
- Clinical Trials Network - San Diego
Illinois
- Rush University Medical Center - Chicago
- DM Clinical Research/Southwest Gastroenterology - Oak Lawn
- Southern Illinois University School of Medicine - Springfield
- Carle Foundation Hospital dba Carle Cancer Center - Urbana
Louisiana
- MZS Research, LLC - Metairie
- Delta Research Partners - Monroe
- Louisiana Research Center, LLC - Shreveport
- Clinical Trials of America, LLC - West Monroe
Connecticut
- Gastroenterology Associates of Fairfield County, P.C. - Fairfield
- Connecticut Clinical Research Institute - Hartford
- Yale University - New Haven
Indiana
- Deaconess Clinic, Inc. - Evansville
- Digestive Research Alliance of Michiana, LLC - South Bend
Arizona
- Mayo Clinic - Arizona - Phoenix
Florida
- Guardian Angel Research Center - Tampa
Maryland
- Capitol Research - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2025-05-29 |
What the finished NCT03789162 record still lists
NCT03789162 is an observational study that tracks outcomes without assigning an intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, below the 1,542-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03789162 names 20 study sites across 8 states, led by California, Illinois, Louisiana.
Frequently Asked Questions
What is clinical trial NCT03789162 about?
NCT03789162 is a clinical study titled "Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast". The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for the detection of colorectal cancer (CRC).
What is the current status of trial NCT03789162?
This trial is currently completed. The enrollment target is 850 participants. The study started on 2018-12-20. Estimated completion is 2025-05-29.
What conditions does trial NCT03789162 study?
This clinical trial studies the following conditions: Colorectal Cancer.
Who is sponsoring clinical trial NCT03789162?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03789162 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03789162's enrollment target sits among peer trials
850 56th of 381 higher than 326 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI